Balkan endemic nephropathy risk associates to the hs1.2 Ig enhancer polymorphism

European Journal of Inflammation

Volumn 10, Issue 3, 2012, Pages 393-403

  Frezza, D ^a   Serone, E ^a   Lolli, S ^b   Cianci, R ^b   D'Addabbo, P ^c   Mattioli, C ^a   Giambra, V ^d   Pavlovic, N ^e   Djordjevic, V ^e   Kostic, S ^e   Pandolfi, Franco ^b   Kostic, E ^e  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d BRITISH COLUMBIA CANCER AGENCY   (Canada)

^e UNIVERSITY OF NI   (Serbia)

Author keywords

Balkan Endemic Nephropathy (BEN) patients; DNA genotyping; Genetic of Balkan Endemic Nephropathy; hs1.2 polymorphism; Ig heavy chain regulatory region; Inflammatory factors

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIALYSIS; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMMUNOREGULATION; INFLAMMATION; INFLAMMATORY DISEASE; INTERSTITIAL NEPHRITIS; MAJOR CLINICAL STUDY; MALE; SERBIA;

EID: 84873431673     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1201000315     Document Type: Article

References (33)

1. Toncheva D, Dimitrov T, Stojanova S. Etiology of Balkan endemic nephropathy: a multifactorial disease? EurJ Epidemiol 1998; 14:389-94.
2. Schiller A, Gusbeth-Tatomir P, Pavlovic N, Ferluga D, Spasovski G, Covic A. Balkan endemic nephropathy: a still unsolved puzzle. J Nephrol 2008; 21:673-80.
3. Gluhovschi G, Margineanu F, Velciov S, et al. Fifty years of Balkan endemic nephropathy in Romania: some aspects of the endemic focus in the Mehedinti county. Clin Nephrol 2011; 75:34-48.
4. Djukanovic L, Marinkovic J, Maric I, Lezaic V, Dajak M, Petronic D, Matic M, Bukvic D. Contribution to the definition of diagnostic criteria for Balkan endemic nephropathy. Nephrol Dial Transplant 2008; 23:3932-8.
5. Stefanovic V, Polenakovic M. Fifty years of research in Balkan endemic nephropathy: where are we now? Nephron Clin Pract 2009; 112:c51-6.
6. Atanasova SY, von Ahsen N, Toncheva DI, Dimitrov TG, Oellerich M, Armstrong VW. Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN). Clin Biochem 2005; 38:223-8.
7. Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem. Kidney Int 2008; 74:158-69.
8. Colin P, Koenig P, Ballereau C, Phe V, Berthon N, Villers A, Biserte J, Roupret M. [Sporadic upper urinary tract urothelial cell carcinomas: identification of interaction between toxic carcinogens and individuals genetic susceptibility]. Prog Urol 2010; 20:1-10.
9. Jankovic S, Bukvic D, Marinkovic J, Jankovic J, Maric I, Djukanovic L. Time trends in Balkan endemic nephropathy incidence in the most affected region in Serbia, 1977-2009: the disease has not yet disappeared. Nephrol Dial Transplant 2011; 26:3171-6.
10. Bunnell JE, Tarn CA, Lerch HE, Orem WH, Pavlovic N. Evaluating nephrotoxicity of high- molecular-weight organic compounds in drinking water from lignite aquifers. J Toxicol Environ Health A 2007; 70:2089-91.
11. Garcia-Bailo B, Toguri C, Eny KM, El-Sohemy A. Genetic variation in taste and its influence on food selection. OMICS 2009; 13:69-80.
12. Wooding S, Gunn H, Ramos P, Thalmann S, Xing C, Meyerhof W. Genetics and bitter taste responses to goitrin, a plant toxin found in vegetables. Chem Senses 2010; 35:685-92.
13. Toncheval DI, Atanassova SY, Gergov TD, Todorovska EG, Roeva IG, Georgiev TH, Fink-Gremmels J, Zaharieva BM. Genetic changes in uroepithelial tumors of patients with Balkan endemic nephropathy. J Nephrol 2002; 15:387-93.
14. Stefanovic V, Djukanovic L, Cukuranovic R, et al. Beta2-microglobulin and alpha1-microglobulin as markers of Balkan endemic nephropathy, a worldwide disease. Ren Fail 2011; 33:176-83.
15. Karmaus W, Dimitrov P, Simeonov V, Tsolova S, Batuman V. Offspring of parents with Balkan Endemic Nephropathy have higher C-reactive protein levels suggestive of inflammatory processes: a longitudinal study. BMC Nephrol 2009; 10:10.
16. Frezza D, Giambra V, Tolusso B, et al. Polymorphism of immunoglobulin enhancer element HS1,2A: allele *2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency. Ann Rheum Dis 2007; 66:1210-5.
17. Tolusso B, Frezza D, Mattioli C, et al. Allele *2 of the HS1,2A enhancer of the Ig regulatory region associates with rheumatoid arthritis. Ann Rheum Dis 2009; 68:416-9.
18. Cianci R, Giambra V, Mattioli C, et al. Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. J Invest Dermatol 2008; 128:1920-4.
19. Chatterjee S, Ju Z, Hassan R, Volpi SA, Emelyanov AV, Birshtein BK. Dynamic changes in binding of immunoglobulin heavy chain 3′ regulatory region to protein factors during class switching. J Biol Chem 2011; 286:29303-12.
20. D'Addabbo P, Scascitelli M, Giambra V, Rocchi M, Frezza D. Position and sequence conservation in Amniota of polymorphic enhancer HS1.2 within the palindrome of IgH 3'Regulatory Region. BMC Evol Biol 2011; 11:71.
21. Pinaud E, Marquet M, Fiancette R, Peron S, Vincent-Fabert C, Denizot Y, Cogne M. The IgH locus 3′ regulatory region: pulling the strings from behind. Adv Immunol 2011; 110:27-70.
22. Vincent-Fabert C, Fiancette R, Pinaud E, Truffinet V, Cogne N, Cogne M, Denizot Y. Genomic deletion of the whole IgH 3′ regulatory region (hs3a, hs1,2, hs3b, and hs4) dramatically affects class switch recombination and Ig secretion to all isotypes. Blood 2010; 116:1895-8.
23. Giambra V, Fruscalzo A, Giufre M, Martinez-Labarga C, Favaro M, Rocchi M, Frezza D. Evolution of human IgH3'EC duplicated structures: both enhancers HS1,2 are polymorphic with variation of transcription factor's consensus sites. Gene 2005; 346:105-14.
24. Fernando TM, Ochs SD, Liu J, Chambers-Turner RC, Sulentic CE. 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Induces Transcriptional Activity of the Human Polymorphic hs1,2 Enhancer of the 3'Igh Regulatory Region. J Immunol 2012; 188:3294-306.
25. Frezza D, Giambra V, Mattioli C, et al. Allelic frequencies of 3′ Ig heavy chain locus enhancer HS1,2-A associated with Ig levels in patients with schizophrenia. Int J Immunopathol Pharmacol 2009; 22:115-23.
26. Aupetit C, Drouet M, Pinaud E, Denizot Y, Aldigier JC, Bridoux F, Cogne M. Alleles of the alpha1 immunoglobulin gene 3′ enhancer control evolution of IgA nephropathy toward renal failure. Kidney Int 2000; 58:966-71.
27. Frezza D, Tolusso B, Giambra V, et al. Polymorphisms of the IgH enhancer HS1.2 and risk of systemic lupus erythematosus. Ann Rheum Dis 2012.
28. Frezza D, Giambra V, Cianci R, et al. Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease. Scand J Gastroenterol 2004; 39:1083-7.
29. Giambra V, Cianci R, Lolli S, et al. Allele *1 of HS1.2 enhancer associates with selective IgA deficiency and IgM concentration. J Immunol 2009; 183:8280-5.
30. Stefanovic V, Jelakovic B, Cukuranovic R, et al. Diagnostic criteria for Balkan endemic nephropathy: proposal by an international panel. Ren Fail 2007; 29:867-80.
31. Cukuranovic R, Petrovic B, Cukuranovic Z, Stefanovic V. Balkan endemic nephropathy: a decreasing incidence of the disease. Pathol Biol (Paris) 2000; 48:558-61.
32. Ju Z, Chatterjee S, Birshtein BK. Interaction between the immunoglobulin heavy chain 3′ regulatory region and the IgH transcription unit during B cell differentiation. Mol Immunol 2011; 49:297-303.
33. Kim EC, Edmonston CR, Wu X, Schaffer A, Casali P. The HoxC4 homeodomain protein mediates activation of the immunoglobulin heavy chain 3′ hs1,2 enhancer in human B cells. Relevance to class switch DNA recombination. J Biol Chem 2004; 279:42258-69.